This may reflect an improvement brought about by prop ranolol in the limbic regulation of stimulus and response processes.
There is growing evidence that propranolol, widely known for its beta-adrenoceptor blocking properties, also controls psychotic symptoms in patients with schizophrenia, mania and some organic psychoses. Evidence is drawn largely from uncontrolled clinical investigations (Ats mon and Blum, 1978; Yorkston ci al, 1974; Van Zerssen, 1976; Yorkston et al, 1976; Shep perd, 1979) but there is support for the con clusion from controlled pharmacological trials. In one such trial propranolol or placebo was added to existing neuroleptic medication in chronic schizophrenic patients with florid features (Yorkston ci al, 1977) ; in another trial, propranolol and chlorpromazine were com pared as sole drugs in schizophrenic patients, most of whom had been recently admitted to hospital and were not on antipsychotic drugs (Yorkston, Zaki, Weller, Gruzelier and Hirsch, unpublished) .
The electrodermal orienting response to tones repeated at intervals of about half a minute were also examined. This response reflects a transient increase in sweating mediated by the sympa thetic branch of the autonomic nervous system and is part of the organism's orientational re actions to a novel stimulus. Schizophrenic patients on propranolol, whether in racemic or dextro form, showed response patterns closer to those of normal controls than of schizophrenic patients on phenothiazines (Gruzelier, 1978; Gruzelier and Yorkston, 1978; Gruzelier ci al, 1979; Gruzelier and Connolly, 1980) . With or without neuroleptics there was evidence of hyper-or hypo-responding, but on prop ranolol hyper-responding in the form of slow habituationwas absent,and in fact, habituation was faster in patients than in normal controls. Additionally, there were fewer electrodermal patterns showing an absence of orienting responses in patients on propranolol than on phenothiazines or free of drugs, and studies of patients before treatment and after the admin istration of propranolol showed that some patients non-responsive before drugs after propranolol exhibited responses which habitu ated normally. These effects, which were in dependent of tonic levels of sweating, indicated that propranolol had both excitatory and in hibitory effects, suggesting a modulation of the orienting response and its rate of habituation. The phasic electrodermal orienting response to discrete stimuli without attentional relevance, while triggered by a mechanism located in the brain-stem, is under a hierarchy of central influences (Wang, 1964; Davison and Koss, 1975; Gruzelier, 1979) . These include limbic structures such as the amygdala and hippo campus which also influence attention (e.g. Pribram and McGuinness, 1975) . Propranolol has been found to act on the hippocampus (Massuoka and Hansson, 1968; Garvey and Ram, 1975a, b; Ram, Hesse and Heilman, 1977) and possibly the amygdala (Richardson, 1974) to such an extent that after intravenous administration in animals concentrations were higher in the hippocampus than in other areas of the central nervous system that were examined (Massuoka and Hansson, 1968; Garvey and Ram, 1975b) . It was our contention that some of the central influences of propranolol might be distinguished from other neuroleptics by actions within the limbic system.
The present study involved the measurement of reaction times to an aversive noise. On neurophysiological and behavioural grounds a drug which facilitates habituation might also facilitate inhibition of a response to avoid noise. Furthermore, a drug which acts to facilitate orientation reactions might also improve be haviour that requires an active avoidance response. A change in both types of avoidance behaviour would support the notion that the influence of propranolol on behaviour is modu latory, thereby facilitating the integration of stimulus and response processing, rather than having simply excitatory, or alternatively inhibitory, functions.
Subjects
Seventeen patients, all diagnosed unambigu ously as schizophrenic with the help of the Present State Examination (Wing et al, 1974) by two consultant psychiatrists, were tested: ten were on propranolol (three as the sole drug) and seven with neuroleptics as well and seven on conventional neuroleptics only. They were compared with thirteen normal controls. The average dose of propranolol when prescribed as the sole drug was 190 mg/day and when combined with other drugs was 610 mg/day (range 160â€"1120mg). The mean dose of other antipsychotic drugs, expressed as the chior promazine equivalent, was 724 mg/day (range 120 to 2200 mg) when combined with prop ranolol and 746 mg/day (range 50â€"! 750 mg) without propranolol.
The other neuroleptics consistedof:â€"fluphenazine decanoate, tn fluoperazine, flupenthixol decanoate and halo peridol.In addition,most patientsin both groups received orphenadrine or benzhexol. Patients were randomly assigned to the treat ment with or without propranolol.
On average, treatment with propranolol lasted for 13 weeks (range 6 to 24 weeks). The ages of the patients ranged from 19 to 57 years with a mean of 41 years for those on prop ranolol and 43 years for those not on prop ranolol. Their ages of onset ranged from 16 to 49 with a mean age of 28 years for both groups.
The ages of the normal subjects ranged from 24 to 56. On average, they were five years younger than the patients, however none of the correlations between age and the four per formance measures were statistically significant (r. =0.37,0.11,0.19, â€"¿ 0.18).
Method
The avoidance learning paradigm involved a manual reaction time (RT) to an auditory stimulus. The experimental design consisted of four blocks of trials.
Run I: Baseline R T
Twelve presentations of a 79 cIBA, equal mark-space ratio, square wave of period 2 msecs, 200 msecs in duration simultaneously to both ears at intervals of 6 to 8 seconds, with manual responses.
Run 11: Familiarization
In this sequence the subject was required simply to remember the different stimuli presented. There were three presentations of the imperative stimulus and three trials on which the imperative stimulus was preceded 500 msecs earlier by a warning signalâ€"69 .5 dBA, equal mark-space ratio, square wave of period 4 msecs and 400 msecs in duration. Finally, there was a single presentation of an aversive noise of 88 dBA consisting of a 3-1 mark-space ratio rectangular wave with a 4 msec period and lasting for five seconds.
Run III: Active Avoidance
Twenty four trials in 12 of which (randomly) the imperative tone was preceded by a warning signal. The inter-trial intervals varied between 10 and 12.5 seconds. The subject was instructed to respond as quickly as possible to the im perative tone. When the imperative tone was preceded by a warning the subject was expected to give an especially short reaction time, other wise the aversive noise would be presented. The RTs in trials where the imperative tone was presented alone were used to calculate a running mean RT. The aversive noise was presented after an interval of 8 seconds if the RT was slower than the subject's mean RT or if the subject omitted a response.
Run IV: Passive Avoidance
A repeat of III in which the subject was now instructed to respond only to imperative tones that occurred without the warning signal, i.e. to withhold a response when the imperative tone was preceded by the warning. If the response was made either to the warning or to the im perative tone paired with the warning, the aversive noise was presented eight seconds after the imperative tone.
The subject was seated alone in a sound attenuated room and could be observed through a one-way mirror. Reaction times were mon itored trial by trial via a display and stimulus presentation and responses were computerized. Heart rate from lead 1 electrocardiogram place ments was also recorded and will be the subject of another report.
Scoring Indices
Four measures were calculated:
(1) an active avoidance index calculated as the number of trials without errors when the warning was paired with the im perative tone, i.e. rapid responses were given to the imperative tone; (2) the number of inappropriate responses during active avoidance, calculated as the number of responses to the warning signal and the aversive noise; (3) a passive avoidance index calculated as the number of withheld responses to the imperative signal when it was paired with the warning minus the number of withheld responses on trials when the signal was presented alone; (4) inappropriate responses calculated as the number of responses to the warning stimulus and aversive noise.
Results
On all indices the patients on propranolol did better than those on conventional medication alone. There were no differences between the patients on propranolol and the controls and both were superior to the phenothiazine only group, except that the control and pheno thiazine group were alike in the number of inappropriate responses in passive avoidance. These impressions were confirmed by the Mann Whitney testusing Kendall's S to correctfor ties, (see Table I ). Patients on propranolol as sole drug were no different from those in whom it was combined with other neuroleptics.
Changes in performance across blocks of trials were examined to determine whether the differ ence in the group mean results occurred because of a gradual improvement, suggestive of learn ing, or were constant over time and might simply reflect group differences in performance and/or in understanding the instructions. The results grouped in blocks of trials are shown in Figs 1 and 2 and indicate that a reduction in errors did take place from the first to subsequent blocks in most cases.
The active avoidance scores were examined with distribution free multiple comparisons based on Friedman Rank Sums (Holiander and Wolfe, 1973) . The first block of three trials was compared with each remaining block. The propranolol group showed fewer errors in the last block compared with the first (P <0.05) and there was a progressive reduction in errors over blocks (Page's L = 270.5, P <0.05). In the control group there were fewer errors in the second block than in the first (P <0.05), after which there were no further reliable changes in performance.
In the phenothiazine group no comparison reached significance but a trend test showed progressive improvement over the first three blocks which just fell short of significance (Pages L = 89.5; L = 91.0, P <0.05). In other words, there was evidence of learning in Of the remainder, 4/5 on propranolol showed some improvement across blocks as did 3/6 on phenothiazines.
In the control group, whereas 5/9 showed improve ment, 4/9 showed an increase in errors in the last two blocks. Thus the patients on prop ranolol in all but one case showed either no errors from the beginning, or a sustained improvement over time. This contrasted with 1 2
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In the passive avoidance task, see Fig 2 , the results were more complex. Firstly the per formance of half (5/10) of the patients on prop ranolol was free of errors throughout, compared 
Means and standard deviations of BPRS subscales on the two rating occasions
the controls in whom about a third were unable to sustain an error-free performance compared with 1/7 patients on phenothiazines whereas 2/7 patients maintained a high level of errors. Regarding overall RTs, the means (in milliseconds) of the groups for the baseline con dition were as follows:â€" control 199.7, a 54. 1; propranolol 357.3, a 147. 1 and phenothiazine 323.4, a 92.9. In an analysis of variance, in cluding all conditions, there was a Group main effect (F = 7.71, df, 2,27, P <0.002). ScheffÃ© comparisons indicated no difference between the patients' groups but longer RTs in patients than controls :â€" control and propranolol groups (P <0.01); control and phenothiazine groups (P <0.05).
There was no significant Group x Conditions interaction.
In order to determine whether superior avoidance learning on propranolol was due purely to the pharmacological influence of the drug or was coincidental with clinical improve ment on drug, we examined psychiatrist ratings which were available for all but one patient in each group on the Brief Psychiatric Rating Scale (Overall and Gorham, 1962) . These were obtained immediately before treatment with propranolol and close to, or on the day of testing, and at comparable intervals with the patients on phenothiazines.
The individual items were grouped into a schizophrenia thought disorder scale, a scale of schizophrenic symp toms excluding thought disorder, and a non schizophrenia scale (see Yorkston et al, 1977) . The results were examined with analysis of variance.
The group mean results are shown in Table  II . Unlike the patients on phenothiazines, those on propranolol were improved by their treat ment, as shown by a significant Group x Time interaction (F = 5.35, df, 1,13, P <0.03), which was due to the propranolol group (ScheffÃ©test, P <0.05) not the phenothiazine group. The groups were also differentiated by the effect of drugs on the quality of symptoms. ScheffÃ©tests indicated that at the beginning the groups showed comparable levels of symptoms but propranolol improved schizophrenic symp toms (P <0.05) leaving non-schizophrenic symptoms unaltered. The superior ability of patients on propranolol in performing the avoidance learning tasks therefore coexisted with fewer schizophrenic symptoms. This was examined further by calculating correlations (Spearman's) between the schizophrenia sub scales at the time of testing and in the case of the propranolol group the improvement on the scales with the various learning indices. Only with passive avoidance learning were significant correlations obtained. The more the improve ment in thought disorder (r = . 71, P <.05) and the less the evidence of other schizophrenic symptoms (r = â€"¿ .83, P <.01) the better the learning on propranolol. There were no significant relations on phenothiazines.
Discussion
Demonstration of propranolol's influencehas been extended beyond a sensory gating mech anism, implicit in its action on autonomic orienting and habituation processes (Gruzelier and Connolly, 1980) , to include the initiation and withholding of motor responses. That performance on active as well as passive avoidance learning was superior in the patients on propranolol supports our contention that propranolol acts on mechanisms that modulate behaviour through the integration of stimulus and response processes. The limbic system appearsa likely candidate forthese functions.
A standard animal test for a drug's neuroleptic potential has been the disruption of active avoidance behaviour (Janssen, Niemegeers and Schellebens, 1965; Fielding and La!,1978 
